Prevalence of current tobacco use, males in Central Europe and the Baltics
Central Europe and the Baltics: Prevalence of current tobacco use, males was 31.8% in 2024. ▼ Falling
Prevalence of current tobacco use, males in Central Europe and the Baltics, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of male adults.
Analysis
The most recent figure for prevalence of current tobacco use, males in Central Europe and the Baltics is 31.8%, measured in 2024. That is the lowest value across all 9 years on record.
That represents a change of down 1.7% on the previous year and down 14.0% over ten years.
Over the whole period, prevalence of current tobacco use, males in Central Europe and the Baltics peaked at 48.3% in 2000 and was at its lowest, 31.8%, in 2024.
That places Central Europe and the Baltics 24th out of 46 groups with data for 2024, putting it in the middle of the range.
Prevalence of current tobacco use, males in Central Europe and the Baltics, year by year
| Year | % of male adults | Change |
|---|---|---|
| 2000 | 48.3% | — |
| 2005 | 44.1% | -8.7% |
| 2007 | 42.6% | -3.6% |
| 2010 | 40.3% | -5.4% |
| 2015 | 36.9% | -8.3% |
| 2020 | 33.9% | -8.2% |
| 2022 | 32.8% | -3.2% |
| 2023 | 32.3% | -1.6% |
| 2024 | 31.8% | -1.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.0% | 42.6% | 48.3% | 3 |
| 2010s | 38.6% | 36.9% | 40.3% | 2 |
| 2020s | 32.7% | 31.8% | 33.9% | 4 |
Countries ranked near Central Europe and the Baltics
More health data for Central Europe and the Baltics
- Population ages 30-34, male, annual growth rate -4.09 % change on previous year (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -1.57 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -1.55 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0319 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, annual growth rate -3.51 % change on previous year (2025)
- Population ages 25-29, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of current tobacco use, males in Central Europe and the Baltics?
- Prevalence of current tobacco use, males in Central Europe and the Baltics was 31.8% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use, males recorded in Central Europe and the Baltics?
- The highest recorded value was 48.3% in 2000.
- What is the lowest prevalence of current tobacco use, males recorded in Central Europe and the Baltics?
- The lowest recorded value was 31.8% in 2024.
- How does Central Europe and the Baltics rank for prevalence of current tobacco use, males?
- Central Europe and the Baltics ranks 24th out of 46 groups with data for 2024.
- Is prevalence of current tobacco use, males rising or falling in Central Europe and the Baltics?
- Over the last ten years it is down 14.0%. The long-run trend across the full record is falling.
- Where does this Central Europe and the Baltics data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use, males (% of male adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.